Stanford University
Showing 421-440 of 506 Results
-
Christoph Thaiss
Assistant Professor of Pathology
Current Research and Scholarly InterestsThe Thaiss Lab investigates how gut-brain interactions influence health and disease. By studying microbiome-host communication, the lab explores how microbial signals impact immune function, metabolism, and neurological health. Using multi-omic technologies and computational models, they aim to uncover mechanisms underlying inflammation, neurological disorders, and metabolic diseases. Their research supports the development of personalized therapies targeting the gut-brain axis.
-
Megan Troxell
Professor of Pathology
Current Research and Scholarly InterestsBreast pathology, renal pathology, transplant pathology, immunohistochemistry
-
Albert Tsai, M.D., Ph.D.
Assistant Professor of Pathology
BioDr. Tsai received his undergraduate training at the University of California, Los Angeles (B.S., Biochemistry, summa cum laude), followed by combined medical and graduate training at the University of Southern California (M.D., Ph.D., Biochemistry). He completed anatomic and clinical pathology (AP/CP) residency and hematopathology fellowship at Stanford University, receiving board certification in AP/CP and hematopathology. As an instructor, he performed clinical diagnostic duties on the hematopathology service while doing postdoctoral training in the laboratory of Dr. Sean Bendall, with funding from the Damon Runyon Cancer Research Foundation.
As a physician and hematopathologist, he seeks to mechanistically dissect myelodysplastic syndromes (MDS) using highly-multiplexed immunophenotyping — mass cytometry / cytometry by time-of-flight (CyTOF) and multiplexed ion beam imaging (MIBI). MDS is an especially complex and heterogeneous disease of abnormal blood cell development with increasing prevalence and few treatments. By combining practical experience clinically diagnosing MDS, next generation single cell proteomic approaches, fundamental discoveries in the biology of MDS, and knowledge of clinical laboratory testing, we hope to develop new clinical diagnostics for personalizing MDS therapies and therapeutic monitoring.
His clinical diagnostic duties are on the hematopathology service, primarily in the diagnosis of MDS, leukemias, lymphomas, and other hematopoietic diseases from blood, bone marrow, and tissue samples. -
Mindy Tsai
Sr Res Scientist-Basic Ls, Pathology Sponsored Projects
BioMindy Tsai is Sr. Research Scientist in the Department of Pathology. She received the D.M.Sc. (Doctor of Medical Sciences) in Oral Biology from Harvard School of Dental Medicine and completed her postdoctoral training at Harvard Medical School. Dr. Tsai’s research focuses on studies that are designed to understand the regulation of mast cell and basophil development and to elucidate the roles of these cells in health and disease. Dr. Tsai’s research approaches include in vitro analyses of mast cells and basophils in human and mice, as well as using mouse models of disease to investigate the effector and immunoregulatory functions of these cells in vivo.
-
Lev Tsypin
Postdoctoral Scholar, Pathology
Current Research and Scholarly InterestsI am working with Botryococcus braunii, a species of freshwater microscopic algae. This organism is unique among plants in that it secretes copious amounts of oil that is chemically analogous to petroleum. This organism may be the key to developing a cheap and sustainable alternative to fossil fuels, but we do not yet have the tools to engineer or optimize its oil production. My work aims to bridge this gap.
-
Matt van de Rijn
Sabine Kohler, MD, Professor of Pathology, Emeritus
Current Research and Scholarly InterestsOur research focuses on molecular analysis of human soft tissue tumors (sarcomas) with an emphasis on leiomyosarcoma and desmoid tumors. In addition we study the role of macrophages in range of malignant tumors.
-
Capucine Van Rechem
Assistant Professor of Pathology (Pathology Research)
Current Research and Scholarly InterestsMy long-term interest lies in understanding the impact chromatin modifiers have on disease development and progression so that more optimal therapeutic opportunities can be achieved. My laboratory explores the direct molecular impact of chromatin-modifying enzymes during cell cycle progression, and characterizes the unappreciated and unconventional roles that these chromatin factors have on cytoplasmic function such as protein synthesis.
